Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models.
Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models.
复制标题
DOI:
10.2217/nnm.12.209
复制
发表时间:
2013-11
期刊:
影响因子:
5.5
通讯作者:
Kevin C Weng;R. Hashizume;C. Noble;L. Serwer;D. Drummond;D. Kirpotin;Anne M. Kuwabara;Lucy X Chao-Lucy-X-C
中科院分区:
文献类型:
--
作者:
Kevin C Weng;R. Hashizume;C. Noble;L. Serwer;D. Drummond;D. Kirpotin;Anne M. Kuwabara;Lucy X Chao-Lucy-X-C
AIM The aim of this work is to evaluate combining targeting strategy and convection-enhanced delivery in brain tumor models by imaging quantum dot-immunoliposome hybrid nanoparticles. MATERIALS & METHODS An EGF receptor-targeted, quantum dot-immunoliposome hybrid nanoparticle (QD-IL) was synthesized. In vitro uptake was measured by flow cytometry and intracellular localization was imaged by confocal microscopy. In the in vivo study, QD-ILs were delivered to intracranial xenografts via convection-enhanced delivery and fluorescence was monitored noninvasively in real-time. RESULTS QD-ILs exhibited specific and efficient uptake in vitro and exhibited approximately 1.3- to 5.0-fold higher total fluorescence compared with nontargeted counterpart in intracranial brain tumor xenografts in vivo. CONCLUSION QD-ILs serve as an effective imaging agent in vitro and in vivo, and the data suggest that ligand-directed liposomal nanoparticles in conjunction with convection-enhanced delivery may offer therapeutic benefits for glioblastoma treatment as a result of specific and efficient uptake by malignant cells.